2018
DOI: 10.1080/24750573.2018.1468637
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative parameters, oxidative DNA damage, and urotensin-II in schizoaffective disorder patients

Abstract: OBJECTIVE: Complexity of schizoaffective disorder makes the identification of its pathophysiology a great challenge and there are very limited published data about the role of oxidative stress. Oxidative DNA damage has not been investigated in schizoaffective disorder. Therefore, we aimed to evaluate oxidative DNA damage together with oxidative stress and urotensin-II in patients with schizoaffective disorder. METHODS: Fifty-four patients who were diagnosed as schizoaffective disorder bipolar type (27 of them … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 54 publications
(63 reference statements)
1
2
0
Order By: Relevance
“…There was no upregulation of DNA damage response and endoplasmic and mitochondrial UPR in the tested conditions. This is in agreement with the reports of no increased oxidative DNA damage in schizophrenia [ 9 , 38 ]. UPR induction in the endoplasmic reticulum of liver cells was reported after a single aripiprazole treatment at about 10 times higher concentrations [ 39 ].…”
Section: Discussionsupporting
confidence: 94%
See 1 more Smart Citation
“…There was no upregulation of DNA damage response and endoplasmic and mitochondrial UPR in the tested conditions. This is in agreement with the reports of no increased oxidative DNA damage in schizophrenia [ 9 , 38 ]. UPR induction in the endoplasmic reticulum of liver cells was reported after a single aripiprazole treatment at about 10 times higher concentrations [ 39 ].…”
Section: Discussionsupporting
confidence: 94%
“…The results may differ because of interindividual variability, different populations, i.e., drug-naive and medicated patients, different antipsychotics used and assessment in different tissues. Reports of lower antioxidant capacity and lower antioxidant levels in schizophrenia patients’ plasma are consistent [ 38 , 41 , 42 , 43 ], as well as those of weaker antioxidant defenses in their cerebrospinal fluid [ 9 ]. It would be interesting to see whether ARI has a similar antioxidative effect in other tissues as we report here in liver cells.…”
Section: Discussionmentioning
confidence: 94%
“…Details of the search results are presented in eFigure 1 in the Supplement. We identified 82 studies fulfilling the inclusion criteria, comprising 205 patient vs control group comparisons and a total of 10 151 patient and 10 532 control observations. Seven studies had interventions, comprising a total of 15 preintervention-postintervention comparisons.…”
Section: Resultsmentioning
confidence: 99%